Events

View All
    Join BIOCYTOGEN at Keystone Symposia: Obesity Therapeutics

    Join BIOCYTOGEN at Keystone Symposia: Obesity Therapeutics

    January 26, 2026
    Share on:

    We want to share that Biocytogen will be attending the Keystone Symposia: Obesity Therapeutics conference in Colorado. Obesity is a major health challenge that is also contributing to other medical issues, such as type 2 diabetes, cardiovascular disease, and certain cancers. This meeting will examine the latest discoveries on obesity drug mechanisms and their unprecedented effectiveness in weight loss and disease risk reduction. Come connect with our team to learn more about how our mouse models and integrated preclinical solutions are accelerating breakthroughs in metabolic disease research. 

    What is Keystone Symposia: Obesity Therapeutics 

    Founded in 1972, Keystone Symposia on Molecular and Cellular Biology is a non-profit producer of international conferences designed by field experts to support all generations of research leaders. Each conference is arranged to maximize networking opportunities, allowing for new perspectives and greater participation from cross-disciplinary collaborations.

    Event Overview  

    Date: January 26th - 29th, 2026

    Venue: Keystone Resort, Keystone, CO 80435

    Event Schedule  

    For more information, please refer to the event program.

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

    We look forward to seeing you in Keystone!